Hillstream BioPharma, Inc. (NASDAQ:HILS – Get Free Report)’s share price traded up 1.5% on Monday . The stock traded as high as $2.03 and last traded at $2.03. 33,477 shares were traded during trading, a decline of 98% from the average session volume of 1,388,685 shares. The stock had previously closed at $2.00.
Hillstream BioPharma Price Performance
The business has a fifty day moving average of $2.09 and a 200-day moving average of $2.43. The stock has a market cap of $35.73 million, a PE ratio of -2.82 and a beta of 3.08.
Hillstream BioPharma Company Profile
Hillstream BioPharma, Inc, a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors.
Featured Articles
- Five stocks we like better than Hillstream BioPharma
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Oracle Announces Game-Changing News for the AI Industry
- How to Invest in Small Cap Stocks
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- What is diluted earnings per share (Diluted EPS)?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Hillstream BioPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hillstream BioPharma and related companies with MarketBeat.com's FREE daily email newsletter.
